NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
University Health Network, Toronto
Grupo Espanol de Investigacion en Sarcomas
Blokhin's Russian Cancer Research Center
Merck Sharp & Dohme LLC
Stanford University